Tag: opioid

June 1, 2019
FDA Proposes Fixed-Quantity Blister Packaging for Certain Opioids

In a call for public comment, the FDA believes that reducing excess opioid supplies can lower opioid misuse, abuse, and overdose.

READ MORE
May 9, 2019
FDA Approves First Generic Naloxone Nasal Spray for Opioid Overdose

The life saving antidote for opioid overdose will soon be available in a consumer-friendly, generic nasal spray.

READ MORE
May 7, 2019
Negative Impacts of Combining Antidepressants with Opioids and Benzodiazepines

Combining all three drugs can reduce claim closure rates to 58.3%, with average claim costs of $94,000.

READ MORE
May 1, 2019
National Institute of Health to Launch $350 Million Opioid Intervention Study

Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.

READ MORE
April 9, 2019
FDA Tightens Restrictions for Transmucosal Fentanyl Products

New changes to REMS safety programs will require stronger treatment documentation and oversight.

READ MORE
April 7, 2019
The Impact of the Changing Workforce

The workforce is aging, getting younger, and gaining more women, all at once. What does that mean for claims management?

READ MORE
April 2, 2019
Oklahoma Reaches $270 Million Settlement with Opioid Manufacturer

Various state and local governments have sued drug developers for the harms of the opioid epidemic, and this could be the first of many settlements.

READ MORE
March 8, 2019
Opioid Imbalance: Risk Disparities Among Diverse Patient Populations

Demographic factors such as gender, ethnicity, socioeconomic status, age, and location can impact opioid risks.

READ MORE
February 8, 2019
Marijuana – What to Expect in 2019 and Beyond

Dr. Robert Goldberg and Sandy Shtab talk with Risk & Insurance about changing attitudes and policies around medical marijuana, its potential role in reducing reliance on opioids, and what this can mean for payers, employers, patients and PBMs.

READ MORE
February 1, 2019
Opioid Marketing Tied to Higher Prescribing and Overdose

A new JAMA study finds that increased county-level opioid marketing was tied to elevated overdose mortality.

READ MORE
lockenvelopephone-handsetmenucross-circle